Titlebook: Clinical Evaluation of Medical Devices; Principles and Case Karen M. Becker,John J. Whyte Book 2006Latest edition Humana Press 2006 Monito

銀河

書目名稱Clinical Evaluation of Medical Devices影響因子(影響力)




書目名稱Clinical Evaluation of Medical Devices影響因子(影響力)學(xué)科排名




書目名稱Clinical Evaluation of Medical Devices網(wǎng)絡(luò)公開度




書目名稱Clinical Evaluation of Medical Devices網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Evaluation of Medical Devices被引頻次




書目名稱Clinical Evaluation of Medical Devices被引頻次學(xué)科排名




書目名稱Clinical Evaluation of Medical Devices年度引用




書目名稱Clinical Evaluation of Medical Devices年度引用學(xué)科排名




書目名稱Clinical Evaluation of Medical Devices讀者反饋




書目名稱Clinical Evaluation of Medical Devices讀者反饋學(xué)科排名

老人病學(xué)

Regulatory Requirements for Clinical Studies of Medical Devices and Diagnostics) Act.. Without the exemption, medical devices would have to comply with performance standard, premarket approval, or notification requirements to be lawfully shipped and used for investigational purposes.. Furthermore, itwould be exceedingly difficult—if not impossible—to conduct clinical trials fo

離開可分裂

Requirements for Medicare Coverage and Reimbursement for Medical Devices new technologies. By adopting long- and short-term strategies that incorporate these principles, manufacturers can avoid certain foreseeable delays in bringing devices to market. Although the roadmap for demonstrating to the Food and Drug Administration (FDA) the safety and efficacy of a device has

虛弱的神經(jīng)

難解

consent

HIPAA Compliance in Clinical Researchincreasingly difficult to conduct. Certainly, those involved in clinical research may feel frustrated or confused by HIPAA’s requirements, particularly when the media report that investigators have been denied access to patient records or that patient enrollment in studies has dramatically decreased

consent

勾引

Developing Drug-Device Combination Products With Unapproved Componentsues, companies are driven by the potential therapeutic success of combining two components into a single product. The driving force behind this new enthusiasm is the local delivery of drugs or biologics to a specific tissue, thereby minimizing the exposure of the whole body to potential toxic compou

browbeat

Wall Street’s Perspective on Medical Device Evaluationhis depends largely on its competitive advantage. In the medical device industry, success is categorically linked to new product flow, transitively marrying innovation and shareholder value creation. The medical device industry follows the punctuated equilibrium interpretation of Darwinism rather th

入會